Lakshmi Rajagopal

Lakshmi Rajagopal
Department of Psychiatry & Behavioral Science, Northwestern University, Feinberg School of Medicine, USA.
Funded by Dainippon Sumitomo Pharma Ltd, Reviva Pharmaceuticals, Naurex Pharmaceuticals, and Astellas: to conduct innovative research to unravel receptor mechanisms: 5-HT1A, 5-HT7, 5-HT2A, 5-HT2C, 5-HT6, alpha 7, GABAa, GABAb, D1, D2, receptors in mechanism of medicines for mental disorder like schizophrenia, bipolar disorder, depression, et al. (systemic, local drug administration/ behavioral/neuropathological analyses in C57BL/6 and genetically modified mice).
Research Interest
Neuropsychopharmacology, Neuropharmacology, Behavioral pharmacology, cognition, animal handling, experimental designs, Pharmacology of Preclinical, statistical analyses, and neuropathology